Your browser doesn't support javascript.
loading
The selective c-Met inhibitor capmatinib offsets cisplatin-nephrotoxicity and doxorubicin-cardiotoxicity and improves their anticancer efficacies.
Shaker, Mohamed E; Shaaban, Ahmed A; El-Shafey, Mohamed M; El-Mesery, Mohamed E.
Afiliação
  • Shaker ME; Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.. Electronic address: mshaker2222@yahoo.com.
  • Shaaban AA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Aqaba University of Technology, Aqaba 77110, Jordan.
  • El-Shafey MM; Department of Anatomy, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt; Department of Physiological Sciences, Fakeeh College for Medical Sciences, Jeddah 2537, Saudi Arabia.
  • El-Mesery ME; Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
Toxicol Appl Pharmacol ; 398: 115018, 2020 07 01.
Article em En | MEDLINE | ID: mdl-32333917

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazinas / Proteínas Proto-Oncogênicas c-met / Inibidores de Proteínas Quinases / Cardiotoxicidade / Imidazóis / Rim / Antineoplásicos Limite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazinas / Proteínas Proto-Oncogênicas c-met / Inibidores de Proteínas Quinases / Cardiotoxicidade / Imidazóis / Rim / Antineoplásicos Limite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2020 Tipo de documento: Article